drugset / Trial / NCT00083252
Study of Talabostat and Cisplatin in Advanced Melanoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the antitumor activity and safety of the combination of talabostat and cisplatin in patients with metastatic melanoma.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | talabostat | Small molecule | — | — |